Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | CFD | P00746 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3068166 | 0.80 | CYP1A2 (0.48) | IDO1GAACYP3A4MAPTCYP1A2 | |
| SCHEMBL3062841 | 0.80 | EPHX1 (0.61) | GAAMAPTEPHX2CYP1A2CYP2D6 | |
| SCHEMBL24847549 | 0.79 | CYP1A2 (0.54) | IDO1GAACYP3A4EPHX2CYP1A2 | |
| SCHEMBL1653407 | 0.79 | CYP1A2 (0.54) | IDO1GAACYP3A4EPHX2CYP1A2 | |
| Hydrochloric Acid SCHEMBL10586690 | 0.78 | EPHX1 (0.59) | GAACYP3A4MAPTEPHX2CYP1A2 | |
| SCHEMBL4418820 | 0.76 | LMNA (0.51) | IDO1GAACYP3A4MAPTCYP1A2 | |
| Bromide SCHEMBL25440153 | 0.76 | GAA (0.65) | IDO1GAACYP3A4MAPTLMNA | |
| SCHEMBL8843411 | 0.74 | ALDH1A1 (0.59) | GAAMAPTEPHX2LMNAHDAC3 | |
| SCHEMBL27601024 | 0.74 | NPC1 (0.71) | CYP1A2LMNAPTGS2HDAC3HDAC1 | |
| SCHEMBL11019527 | 0.74 | NPC1 (0.54) | MAPTEPHX2LMNANPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8440300-B2 | Coated polyoxymethylenes | BASF SE (DE) | 2013-05-14 | — | — | US | disclosed |
| CN-101925637-B | Coated polyoxymethylene | BASF SE | 2012-11-21 | — | — | CN | disclosed |
| EP-2235092-B1 | COATED POLYOXYMETHYLENES | BASF SE (DE) | 2012-03-14 | — | — | EP | disclosed |
| CN-101925637-A | Coated polyoxymethylene | BASF SE | 2010-12-22 | — | — | CN | disclosed |
| US-20100291389-A1 | COATED POLYOXYMETHYLENES | BASF SE PATENTS, TRADEMARKS AND LICENSES (DE) | 2010-11-18 | — | — | US | disclosed |
| EP-2235092-A1 | COATED POLYOXYMETHYLENES | BASF SE (DE) | 2010-10-06 | — | — | EP | disclosed |
| US-7572913-B2 | Inhibitors of Rho kinase; N-Benzyloxycarbonyl-4-[N''-(tert-butyloxycarbonyl)hydrazino]piperidine; 4-{[N''-(tert-butyloxycarbonyl)-N'-(1'-propyl)]hydrazino}piperidine | BIOAXONE THERAPEUTIQUE INC. (CA) | 2009-08-11 | — | — | US | disclosed |
| WO-2009092698-A1 | COATED POLYOXYMETHYLENES | BASF SE (DE) | 2009-07-30 | — | — | WO | disclosed |
| CN-1980929-A | 4-substituted piperidine derivatives | BIOAXONE THERAPEUTIQUE INC (CA) | 2007-06-13 | — | — | CN | disclosed |
| EP-1720874-A1 | 4-SUBSTITUTED PIPERIDINE DERIVATIVES | Bioaxone Therapeutique Inc. (CA) | 2006-11-15 | — | — | EP | disclosed |
| EP-0635023-A1 | COVALENTLY CROSS-LINKED OLIGONUCLEOTIDES | ISIS PHARMACEUTICALS, INC. (US) | 1995-01-25 | — | — | EP | disclosed |
| US-5378825-A | Backbone modified oligonucleotide analogs | ISIS PHARMACEUTICALS, INC. (US) | 1995-01-03 | — | — | US | disclosed |
| WO-1994022893-A1 | OLIGONUCLEOSIDE LINKAGES CONTAINING ADJACENT NITROGEN ATOMS | ISIS PHARMACEUTICALS, INC. (US) | 1994-10-13 | — | — | WO | disclosed |
| WO-1994022883-A1 | BACKBONE MODIFIED OLIGONUCLEOTIDES AND THEIR PREPARATION | ISIS PHARMACEUTICALS, INC. (US) | 1994-10-13 | — | — | WO | disclosed |
| WO-1994022454-A1 | OLIGONUCLEOSIDE LINKAGES CONTAINING ADJACENT OXYGEN AND NITROGEN ATOMS | ISIS PHARMACEUTICALS, INC. (US) | 1994-10-13 | — | — | WO | disclosed |
| EP-0586570-A1 | BACKBONE MODIFIED OLIGONUCLEOTIDE ANALOGUES | ISIS PHARMACEUTICALS, INC. (US) | 1994-03-16 | — | — | EP | disclosed |
| EP-0586520-A1 | BACKBONE MODIFIED OLIGONUCLEOTIDE ANALOGS | ISIS PHARMACEUTICALS, INC. (US) | 1994-03-16 | — | — | EP | disclosed |
| WO-1993018052-A1 | COVALENTLY CROSS-LINKED OLIGONUCLEOTIDES | ISIS PHARMACEUTICALS, INC. (US) | 1993-09-16 | — | — | WO | disclosed |
| WO-1992020822-A1 | BACKBONE MODIFIED OLIGONUCLEOTIDE ANALOGUES | ISIS PHARMACEUTICALS, INC. (US) | 1992-11-26 | — | — | WO | disclosed |
| WO-1992020823-A1 | BACKBONE MODIFIED OLIGONUCLEOTIDE ANALOGS | ISIS PHARMACEUTICALS, INC. (US) | 1992-11-26 | — | — | WO | disclosed |